Jackson added $1 billion of buyback room. Where does the cash come from?
Jackson expanded buyback capacity as insurer free capital generation declined. Our comparison tracks capital requirements, parent cash and the unchanged annual return target.
Ticker Byline
Dividends & Buybacks
Dividends, share repurchases and the cash available to support shareholder returns.
PTC Therapeutics can buy $500 million of stock. What else needs that cash?
PTC Therapeutics authorized up to $500 million of share purchases. Our comparison weighs the option against product growth, a completed program purchase and milestones.
Huron's buyback room grows. Why isn't cash keeping pace?
A new authorization follows stronger operating results. Comparing Huron's cash statements shows where the latest quarter's cash slowdown occurred.
JBT Marel trimmed its sales outlook. Why expand buybacks by $500 million?
JBT Marel expanded buyback authority as its sales forecast softened. Our cash comparison shows stronger generation, larger repurchases and a small rise in net debt.
The future capacity payments behind Talen's $1.5 billion buyback
Talen retired shares using an advance against future capacity payments. Its filing details a $157 million finance charge and the cash committed through 2029.
Williams' dividend coverage comes before a much bigger spending bill
Williams reported strong dividend coverage while cash capital spending exceeded operating cash flow. Our comparison explains the measure and follows the project funding, debt and completed Momentum acquisition.
onsemi's buybacks fell 94%. Two cash deals are waiting.
onsemi returned a much smaller share of quarterly free cash flow through buybacks. Our comparison puts the change alongside its cash balance and pending Ferric and Synaptics deals.
Why California Resources raised its dividend after a $315 million loss
California Resources swung to a loss but increased its dividend. Our comparison separates contract valuations, real hedge payments and operating cash flow.
IIPR's adjusted earnings now top its dividend. What changed?
IIPR's AFFO per share moved above its unchanged dividend in Q3. We examine the smaller share count, tenant deposits and income from life-science investments.
Viper's higher base dividend comes with a smaller check
Viper's first dividend under its August policy is below the prior total payout. We compare the declarations, new royalty purchases and higher borrowing.
PROG's lower forecast already counts on its $100 million buyback
PROG executed a $100 million buyback after lowering adjusted earnings guidance that already included its initial share-count benefit.
Krystal has money for buybacks. Several drug milestones need more time.
Krystal’s profitable medicine supports a new buyback plan, but a comparison of August and November updates shows several drug milestones slipping into 2027.
HF Sinclair's $257 million buyback could end REH's board nomination right
HF Sinclair’s planned $257 million buyback could change REH’s board nomination rights. Closing and ownership conditions still matter.
How AutoNation keeps lifting adjusted earnings per share while earning less
AutoNation’s buybacks helped adjusted earnings per share rise. Adjusted profit fell from a year earlier in both the second and third quarters.